| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.076 | 0.8 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |